Real-World Effectiveness of SGLT2 Inhibitors Vs Metformin As First-Line Therapy in Type 2 Diabetes
Document Type
Abstract
Publication Date
5-7-2023
Keywords
oregon; cards; cards abstracts
Abstract
Presented at ISPOR—The Professional Society for Health Economics and Outcomes Research Annual Meeting, May 7-10, 2023, Boston, MA
Clinical Institute
Cardiovascular (Heart)
Specialty/Research Institute
Cardiology
Comments
Rpdriguez PJ, Gratzl S, Lee R, Gilson S, Smits P, Stucky N, Gluckman TJ